Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
This section weighs security guarantees across Pow and Pos, helping readers decide which consensus offers stronger protections for their needs.
24,327 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
With an average $70,000 salary in the crosshairs, this explainer shows the math and the risks behind replacing work i...
A 70-year-old aims to generate $69,600 a year from a $1.1 million portfolio, testing whether higher-yield income stra...
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Whatnot has crossed a historical milestone: one billion orders processed on its live-commerce platform, fueling a $11...
A major rumor suggests Adele reportedly returns London to write and record while she contemplates a long pause from m...
ON Semiconductor slumped about 20% after unveiling an all-stock purchase of Synaptics, triggering questions about dil...
The Army announces a framework allowing private funds to finance and operate base infrastructure, signaling a major s...
In a blazing heat, a senior's routine errand turned into a scam warning. This story reveals how gift card fraud targe...
A retiree who kept spouse’s employer plan past 65 faced a Medicare late enrollment penalty after his wife retired. Th...
Energy markets pivot as renewables rise and fossil fuels adapt; several penny stocks are drawing attention for their ...
A snack brand’s take-private deal sent its stock surging and offered a clear lesson for investors. This guide breaks ...